Evidence map›Paper›PMID 30890743›Full record

ArticleScientific reports2019

The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice.

Jan Chemnitz, Dorothea Pieper, Lena Stich, Udo Schumacher, Stefan Balabanov, Michael Spohn, Adam Grundhoff, Alexander Steinkasserer, Joachim Hauber, Elisabeth Zinser

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jan ChemnitzHeinrich Pette Institute - Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany. jan.chemnitz@hpi.uni-hamburg.de.
Dorothea PieperHeinrich Pette Institute - Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany.
Lena StichDepartment of Immune Modulation, University Hospital Erlangen, Hartmannstrasse 14, 91052, Erlangen, Germany.
Udo SchumacherCenter for Experimental Medicine, Department of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Stefan BalabanovDivision of Hematology, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.
Michael SpohnHeinrich Pette Institute - Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany.
Adam GrundhoffHeinrich Pette Institute - Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany.ORCID 0000-0003-0940-7045
Alexander SteinkassererDepartment of Immune Modulation, University Hospital Erlangen, Hartmannstrasse 14, 91052, Erlangen, Germany.
Joachim HauberHeinrich Pette Institute - Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany.
Elisabeth ZinserDepartment of Immune Modulation, University Hospital Erlangen, Hartmannstrasse 14, 91052, Erlangen, Germany. elisabeth.zinser@uk-erlangen.de.
Leibniz Institute of Virology (LIV) · DEUniversitätsklinikum Erlangen · DEUniversität Hamburg · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ANP32B belongs to a family of evolutionary conserved acidic nuclear phosphoproteins (ANP32A-H). Family members have been described as multifunctional regulatory proteins and proto-oncogenic factors affecting embryonic development, cell proliferation, apoptosis, and gene expression at various levels. Involvement of ANP32B in multiple processes of cellular life is reflected by the previous finding that systemic gene knockout (KO) of Anp32b leads to embryonic lethality in mice. Here, we demonstrate that a conditional KO of Anp32b is well tolerated in adult animals. However, after immune activation splenocytes isolated from Anp32b KO mice showed a strong commitment towards Th17 immune responses. Therefore, we further analyzed the respective animals in vivo using an experimental autoimmune encephalomyelitis (EAE) model. Interestingly, an exacerbated clinical score was observed in the Anp32b KO mice. This was accompanied by the finding that animal-derived T lymphocytes were in a more activated state, and RNA sequencing analyses revealed hyperactivation of several T lymphocyte-associated immune modulatory pathways, attended by significant upregulation of Tfh cell numbers that altogether might explain the observed strong autoreactive processes. Therefore, Anp32b appears to fulfill a role in regulating adequate adaptive immune responses and, hence, may be involved in dysregulation of pathways leading to autoimmune disorders and/or immune deficiencies.

Indexed as

Adaptive ImmunityAnimalsApoptosisCell Cycle ProteinsCell ProliferationEncephalomyelitis, Autoimmune, ExperimentalGene Expression RegulationHumansImmunologic FactorsInflammationMiceMice, KnockoutNerve Tissue ProteinsNuclear ProteinsTh17 CellsAnp32b protein, mouseCell Cycle ProteinsImmunologic FactorsNerve Tissue ProteinsNuclear Proteins

Identifiers

PMID30890743
PMCPMC6424966
OpenAlexW2922523907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.